Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

141 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeting mesothelin receptors with drug-loaded bacterial nanocells suppresses human mesothelioma tumour growth in mouse xenograft models.
Alfaleh MA, Howard CB, Sedliarou I, Jones ML, Gudhka R, Vanegas N, Weiss J, Suurbach JH, de Bakker CJ, Milne MR, Rumballe BA, MacDiarmid JA, Brahmbhatt H, Mahler SM. Alfaleh MA, et al. Among authors: brahmbhatt h. PLoS One. 2017 Oct 23;12(10):e0186137. doi: 10.1371/journal.pone.0186137. eCollection 2017. PLoS One. 2017. PMID: 29059207 Free PMC article.
Bacterially derived 400 nm particles for encapsulation and cancer cell targeting of chemotherapeutics.
MacDiarmid JA, Mugridge NB, Weiss JC, Phillips L, Burn AL, Paulin RP, Haasdyk JE, Dickson KA, Brahmbhatt VN, Pattison ST, James AC, Al Bakri G, Straw RC, Stillman B, Graham RM, Brahmbhatt H. MacDiarmid JA, et al. Among authors: brahmbhatt vn, brahmbhatt h. Cancer Cell. 2007 May;11(5):431-45. doi: 10.1016/j.ccr.2007.03.012. Cancer Cell. 2007. PMID: 17482133 Free article.
Sequential treatment of drug-resistant tumors with targeted minicells containing siRNA or a cytotoxic drug.
MacDiarmid JA, Amaro-Mugridge NB, Madrid-Weiss J, Sedliarou I, Wetzel S, Kochar K, Brahmbhatt VN, Phillips L, Pattison ST, Petti C, Stillman B, Graham RM, Brahmbhatt H. MacDiarmid JA, et al. Among authors: brahmbhatt vn, brahmbhatt h. Nat Biotechnol. 2009 Jul;27(7):643-51. doi: 10.1038/nbt.1547. Epub 2009 Jun 28. Nat Biotechnol. 2009. PMID: 19561595
Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma.
Reid G, Pel ME, Kirschner MB, Cheng YY, Mugridge N, Weiss J, Williams M, Wright C, Edelman JJ, Vallely MP, McCaughan BC, Klebe S, Brahmbhatt H, MacDiarmid JA, van Zandwijk N. Reid G, et al. Among authors: brahmbhatt h. Ann Oncol. 2013 Dec;24(12):3128-35. doi: 10.1093/annonc/mdt412. Epub 2013 Oct 22. Ann Oncol. 2013. PMID: 24148817 Free article.
Nanocell targeting using engineered bispecific antibodies.
Taylor K, Howard CB, Jones ML, Sedliarou I, MacDiarmid J, Brahmbhatt H, Munro TP, Mahler SM. Taylor K, et al. Among authors: brahmbhatt h. MAbs. 2015;7(1):53-65. doi: 10.4161/19420862.2014.985952. MAbs. 2015. PMID: 25523746 Free PMC article.
A Significant Metabolic and Radiological Response after a Novel Targeted MicroRNA-based Treatment Approach in Malignant Pleural Mesothelioma.
Kao SC, Fulham M, Wong K, Cooper W, Brahmbhatt H, MacDiarmid J, Pattison S, Sagong JO, Huynh Y, Leslie F, Pavlakis N, Clarke S, Boyer M, Reid G, van Zandwijk N. Kao SC, et al. Among authors: brahmbhatt h. Am J Respir Crit Care Med. 2015 Jun 15;191(12):1467-9. doi: 10.1164/rccm.201503-0461LE. Am J Respir Crit Care Med. 2015. PMID: 26075427 No abstract available.
miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma.
Williams M, Kirschner MB, Cheng YY, Hanh J, Weiss J, Mugridge N, Wright CM, Linton A, Kao SC, Edelman JJ, Vallely MP, McCaughan BC, Cooper W, Klebe S, Lin RC, Brahmbhatt H, MacDiarmid J, van Zandwijk N, Reid G. Williams M, et al. Among authors: brahmbhatt h. Oncotarget. 2015 Sep 15;6(27):23480-95. doi: 10.18632/oncotarget.4346. Oncotarget. 2015. PMID: 26125439 Free PMC article.
141 results